Primary Article

Protective Effects of Ileal Bypass Versus Administration of Clofibrate on Experimental Hypercholesterolemia and Atherosclerosis in Monkeys*

Authors: RACHEL K. YOUNGER BA, JACK J. CURTIS MD, WILSON H. BUTTS BA, WILLIAM H. SCOTT JR MD

Abstract

ABSTRACT: &NA; This study was designed to compare the ability of distal intestinal bypass versus clofibrate administration to prevent the development of atherosclerosis and hypercholesterolemia in monkeys on a standardized atherogenic regimen. Three groups of monkeys were studied: one group was submitted to intestinal bypass, one group was fed clofibrate, and one group served as dietary controls. Serum cholesterol levels and gross atheromatous lesions were studied. Clofibrate offered moderate protection against experimental hypercholesterolemia and atherosclerosis, but in animals with surgical bypass of the distal one third of the small intestine, the protection appeared to be more complete.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References